BlockRx is a series of initiatives by iSolve which leverage the Blockchain and iSolve’s Advanced Digital Ledger Technology™ (ADLT™). The platform is a comprehensive solution to fully integrate Life Science Researchers, BioPharma, Medical Device Manufactures, and Healthcare Providers to improve Patient Outcomes. The goal for BlockRx is to interconnect systems that do not readily communicate with each other and create data provenance that satisfies regulatory and business requirements. By focusing on creating a network of Trusted Partners that are incentivized, BlockRx provides the solutions for facilitating the transfer of information.
Sponsorship by GPMS. Incorporation
Creation of the iSolce Platform Marketplace for Biotech IP. Partnership with Tech Transfer Office at University of South Dakota.
Creation of the BlockRx project. Partnerships. Development of ADLT.
Partnerships (Intel, YourEncore). BlockRx token offering. Pharma Co acquiring tokens. Live pharma use case. BlockRx token integration. Resource aquisition.
Pharma ecosystem initiation. BlockRx patient application. Resource acquisition. Product development. Expand sales and marketing